메뉴 건너뛰기




Volumn 35, Issue 26, 2014, Pages 1732-1742

Antihypertensive efficacy of angiotensin receptor blockers as monotherapy as evaluated by ambulatory blood pressure monitoring: Ameta-Analysis

Author keywords

Ambulatory blood pressure monitoring; Angiotensin receptor blockers; Hypertension; Meta analysis

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; AZILSARTAN; CANDESARTAN; EPROSARTAN; IRBESARTAN; LOSARTAN; OLMESARTAN; PLACEBO; TELMISARTAN; VALSARTAN; ANTIHYPERTENSIVE AGENT;

EID: 84907934426     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/eht333     Document Type: Article
Times cited : (24)

References (84)
  • 1
    • 55049136834 scopus 로고    scopus 로고
    • Blood pressure lowering efficacy of angiotensin receptor blockers for primary hypertension
    • Review
    • Heran B,Wong M, Heran I, Wright J. Blood pressure lowering efficacy of angiotensin receptor blockers for primary hypertension. Cochrane Database Syst Rev 2008; (4):CD003822. Review.
    • (2008) Cochrane Database Syst Rev , vol.4
    • Heran, B.1    Wong, M.2    Heran, I.3    Wright, J.4
  • 2
    • 0033979994 scopus 로고    scopus 로고
    • Pharmacologic, pharmacokinetic, and therapeutic differences among angiotensin II receptor antagonists
    • Song JC, White CM. Pharmacologic, pharmacokinetic, and therapeutic differences among angiotensin II receptor antagonists. Pharmacotherapy 2000;20:130-139.
    • (2000) Pharmacotherapy , vol.20 , pp. 130-139
    • Song, J.C.1    White, C.M.2
  • 4
    • 42549085390 scopus 로고    scopus 로고
    • Meta-Analysis of randomized controlled trials comparing telmisartan with losartan in the treatment of patients with hypertension
    • Xi GL, Cheng JW, Lu GC. Meta-analysis of randomized controlled trials comparing telmisartan with losartan in the treatment of patients with hypertension. Am J Hypertens 2008;21:546-552.
    • (2008) Am J Hypertens , vol.21 , pp. 546-552
    • Xi, G.L.1    Cheng, J.W.2    Lu, G.C.3
  • 5
    • 0042884278 scopus 로고    scopus 로고
    • Comparison of telmisartan versus losartan: Meta-Analysis of titration-To-Response studies
    • Smith DH, Cramer MJ, Neutel JM, Hettiarachchi R, Koval S. Comparison of telmisartan versus losartan: Meta-analysis of titration-To-Response studies. Blood Press Monit 2003;8:111-117.
    • (2003) Blood Press Monit , vol.8 , pp. 111-117
    • Smith, D.H.1    Cramer, M.J.2    Neutel, J.M.3    Hettiarachchi, R.4    Koval, S.5
  • 8
    • 69449100622 scopus 로고    scopus 로고
    • Preferred reporting items for systematic reviews and meta-Analyses: The PRISMA statement
    • Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. BMJ 2009;339:b2535.
    • (2009) BMJ , vol.339
    • Moher, D.1    Liberati, A.2    Tetzlaff, J.3    Altman, D.G.4
  • 10
    • 0026776749 scopus 로고
    • Variance imputation for overviews of clinical trials with continuous response
    • Follmann D, Elliott P, Suh I, Cutler J. Variance imputation for overviews of clinical trials with continuous response. J Clin Epidemiol 1992;45:769-773.
    • (1992) J Clin Epidemiol , vol.45 , pp. 769-773
    • Follmann, D.1    Elliott, P.2    Suh, I.3    Cutler, J.4
  • 12
    • 0030922816 scopus 로고    scopus 로고
    • Bias in meta-Analysis detected by a simple, graphical test
    • Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629-634.
    • (1997) BMJ , vol.315 , pp. 629-634
    • Egger, M.1    Davey Smith, G.2    Schneider, M.3    Minder, C.4
  • 13
    • 84921702413 scopus 로고    scopus 로고
    • Interaction revisited: The difference between two estimates
    • Altman DG, Bland JM. Interaction revisited: The difference between two estimates. BMJ 2003;326:219.
    • (2003) BMJ , vol.326 , pp. 219
    • Altman, D.G.1    Bland, J.M.2
  • 14
    • 0033917552 scopus 로고    scopus 로고
    • Renoprotective effects of angiotensin II receptor blockade in type 1 diabetic patients with diabetic nephropathy
    • Andersen S, TarnowL, Rossing P, Hansen BV, Parving HH. Renoprotective effects of angiotensin II receptor blockade in type 1 diabetic patients with diabetic nephropathy. Kidney Int 2000;57:601-606.
    • (2000) Kidney Int , vol.57 , pp. 601-606
    • Andersen, S.1    Tarnow, L.2    Rossing, P.3    Hansen, B.V.4    Parving, H.5
  • 15
    • 33645068586 scopus 로고    scopus 로고
    • A placebo-Controlled comparison of the efficacy and tolerability of candesartan cilexetil, 8 mg, and losartan, 50 mg, as monotherapy in patients with essential hypertension, using 36-H ambulatory blood pressure monitoring
    • Baguet JP, Nisse-Durgeat S, Mouret S, Asmar R, Mallion JM. A placebo-Controlled comparison of the efficacy and tolerability of candesartan cilexetil, 8 mg, and losartan, 50 mg, as monotherapy in patients with essential hypertension, using 36-H ambulatory blood pressure monitoring. Int J Clin Pract 2006;60:391-398.
    • (2006) Int J Clin Pract , vol.60 , pp. 391-398
    • Baguet, J.P.1    Nisse-Durgeat, S.2    Mouret, S.3    Asmar, R.4    Mallion, J.M.5
  • 16
    • 0036155522 scopus 로고    scopus 로고
    • A comparative trial of controlled-Onset, extended-Release verapamil, enalapril, and losartan on blood pressure and heart rate changes
    • Bakris G, Sica D, Ram V, Fagan T, Vaitkus PT, Anders RJ. A comparative trial of controlled-Onset, extended-Release verapamil, enalapril, and losartan on blood pressure and heart rate changes. Am J Hypertens 2002;15:53-57.
    • (2002) Am J Hypertens , vol.15 , pp. 53-57
    • Bakris, G.1    Sica, D.2    Ram, V.3    Fagan, T.4    Vaitkus, P.T.5    Anders, R.J.6
  • 17
    • 0043172552 scopus 로고    scopus 로고
    • Antihypertensive efficacy of olmesartan medoxomil and candesartan cilexetil assessed by 24-Hour ambulatory blood pressure monitoring in patients with essential hypertension
    • Brunner HR, Stumpe KO, Januszewicz A. Antihypertensive efficacy of olmesartan medoxomil and candesartan cilexetil assessed by 24-Hour ambulatory blood pressure monitoring in patients with essential hypertension. Clin Drug Investig 2003;23: 419-430.
    • (2003) Clin Drug Investig , vol.23 , pp. 419-430
    • Brunner, H.R.1    Stumpe, K.O.2    Januszewicz, A.3
  • 18
    • 0029817681 scopus 로고    scopus 로고
    • Antihypertensive efficacy of the angiotensin II AT1-Receptor antagonist losartan: Results of a randomized, double-Blind, placebo-Controlled, parallel-Group trial using 24-Hour blood pressure monitoring Ambulatory Blood Pressure Monitoring Study Group
    • Byyny RL. Antihypertensive efficacy of the angiotensin II AT1-Receptor antagonist losartan: Results of a randomized, double-Blind, placebo-Controlled, parallel-Group trial using 24-Hour blood pressure monitoring. Ambulatory Blood Pressure Monitoring Study Group. Blood Press Suppl 1996;2:71-77.
    • (1996) Blood Press Suppl , vol.2 , pp. 71-77
    • Byyny, R.L.1
  • 19
    • 0034986031 scopus 로고    scopus 로고
    • Antihypertensive efficacy and tolerability of low-Dose perindopril/indapamide combination compared with losartan in the treatment of essential hypertension
    • Chanudet X, De Champvallins M. Antihypertensive efficacy and tolerability of low-Dose perindopril/indapamide combination compared with losartan in the treatment of essential hypertension. Int J Clin Pract 2001;55:233-239.
    • (2001) Int J Clin Pract , vol.55 , pp. 233-239
    • Chanudet, X.1    De Champvallins, M.2
  • 20
    • 0038042008 scopus 로고    scopus 로고
    • Antihypertensive efficacy and safety of olmesartan medoxomil compared with amlodipine for mild-To-Moderate hypertension
    • Chrysant SG, Marbury TC, Robinson TD. Antihypertensive efficacy and safety of olmesartan medoxomil compared with amlodipine for mild-To-Moderate hypertension. J Hum Hypertens 2003;17:425-432.
    • (2003) J Hum Hypertens , vol.17 , pp. 425-432
    • Chrysant, S.G.1    Marbury, T.C.2    Robinson, T.D.3
  • 21
    • 0033954240 scopus 로고    scopus 로고
    • Comparison of the efficacy and safety of losartan (50-100 mg) with the T-Type calcium channel blocker mibefradil (50-100 mg) in mild to moderate hypertension
    • Chung O, Hinder M, Sharma AM, Bonner G, Middeke M, Platon J, Unger T. Comparison of the efficacy and safety of losartan (50-100 mg) with the T-Type calcium channel blocker mibefradil (50-100 mg) in mild to moderate hypertension. Fundam Clin Pharmacol 2000;14:31-41.
    • (2000) Fundam Clin Pharmacol , vol.14 , pp. 31-41
    • Chung, O.1    Hinder, M.2    Sharma, A.M.3    Bonner, G.4    Middeke, M.5    Platon, J.6    Unger, T.7
  • 23
    • 34247263709 scopus 로고    scopus 로고
    • Effects of valsartan or amlodipine alone or in combination on plasma catecholamine levels at rest and during standing in hypertensive patients
    • de Champlain J, Karas M, Assouline L, Nadeau R, LeBlanc AR, Dube B, Larochelle P. Effects of valsartan or amlodipine alone or in combination on plasma catecholamine levels at rest and during standing in hypertensive patients. J Clin Hypertens (Greenwich) 2007;9:168-178.
    • (2007) J Clin Hypertens (Greenwich) , vol.9 , pp. 168-178
    • De Champlain, J.1    Karas, M.2    Assouline, L.3    Nadeau, R.4    Leblanc, A.R.5    Dube, B.6    Larochelle, P.7
  • 24
    • 18444416063 scopus 로고    scopus 로고
    • Comparative efficacy of valsartan and olmesartan in mild-To-Moderate hypertension: Results of 24-Hour ambulatory blood pressure monitoring
    • Destro M, Scabrosetti R, Vanasia A, Mugellini A. Comparative efficacy of valsartan and olmesartan in mild-To-Moderate hypertension: Results of 24-Hour ambulatory blood pressure monitoring. Adv Ther 2005;22:32-43.
    • (2005) Adv Ther , vol.22 , pp. 32-43
    • Destro, M.1    Scabrosetti, R.2    Vanasia, A.3    Mugellini, A.4
  • 25
    • 10344248150 scopus 로고    scopus 로고
    • A double-Blind ambulatory blood pressure monitoring study of the efficacy and tolerability of once-daily telmisartan 40 mg in comparison with losartan 50 mgin the treatment of mild-To-Moderate hypertension in Taiwanese patients
    • Ding PY, Chu KM, Chiang HT, Shu KH. A double-Blind ambulatory blood pressure monitoring study of the efficacy and tolerability of once-daily telmisartan 40 mg in comparison with losartan 50 mgin the treatment of mild-To-Moderate hypertension in Taiwanese patients. Int J Clin Pract Suppl 2004;125:16-22.
    • (2004) Int J Clin Pract Suppl , vol.125 , pp. 16-22
    • Ding, P.Y.1    Chu, K.M.2    Chiang, H.T.3    Shu, K.H.4
  • 26
    • 79960797566 scopus 로고    scopus 로고
    • Effect of valsartan, hydrochlorothiazide, and their combination on 24-H ambulatory blood pressure response in elderly patients with systolic hypertension: A ValVET substudy
    • Duprez DA, Weintraub HS, Cushman WC, Purkayastha D, Zappe D, Samuel R, Izzo JL Jr. Effect of valsartan, hydrochlorothiazide, and their combination on 24-H ambulatory blood pressure response in elderly patients with systolic hypertension: A ValVET substudy. Blood Press Monit 2011;16:186-196.
    • (2011) Blood Press Monit , vol.16 , pp. 186-196
    • Duprez, D.A.1    Weintraub, H.S.2    Cushman, W.C.3    Purkayastha, D.4    Zappe, D.5    Samuel, R.6    Izzo, Jr.J.L.7
  • 27
    • 84859892353 scopus 로고    scopus 로고
    • Sustained decrease in blood pressure following missed doses of aliskiren or telmisartan: The ASSERTIVE double-Blind, randomized study
    • Düsing R, Brunel P, Baek I, Baschiera F. Sustained decrease in blood pressure following missed doses of aliskiren or telmisartan: The ASSERTIVE double-Blind, randomized study. J Hypertens 2012;30:1029-1040.
    • (2012) J Hypertens , vol.30 , pp. 1029-1040
    • Düsing, R.1    Brunel, P.2    Baek, I.3    Baschiera, F.4
  • 28
    • 0035127162 scopus 로고    scopus 로고
    • A randomised, placebo-Controlled, double-Blind, crossover study of losartan and enalapril in patients with essential hypertension
    • Fagard R, Lijnen P, Pardaens K, Thijs L, VinckW. A randomised, placebo-Controlled, double-Blind, crossover study of losartan and enalapril in patients with essential hypertension. J Hum Hypertens 2001;15:161-167.
    • (2001) J Hum Hypertens , vol.15 , pp. 161-167
    • Fagard, R.1    Lijnen, P.2    Pardaens, K.3    Thijs, L.4    Vinck, W.5
  • 29
    • 33845602177 scopus 로고    scopus 로고
    • Hydrochlorothiazide added to valsartan is more effective than when added to olmesartan in reducing blood pressure in moderately hypertensive patients inadequately controlled by monotherapy
    • Fogari R, Zoppi A, Mugellini A, Preti P, Destro M, Rinaldi A, Derosa G. Hydrochlorothiazide added to valsartan is more effective than when added to olmesartan in reducing blood pressure in moderately hypertensive patients inadequately controlled by monotherapy. Adv Ther 2006;23:680-695.
    • (2006) Adv Ther , vol.23 , pp. 680-695
    • Fogari, R.1    Zoppi, A.2    Mugellini, A.3    Preti, P.4    Destro, M.5    Rinaldi, A.6    Derosa, G.7
  • 30
    • 41249095681 scopus 로고    scopus 로고
    • Effectiveness of hydrochlorothiazide in combination with telmisartan and olmesartan in adults with moderate hypertension not controlled with monotherapy: A prospective, randomized, open-Label, blinded end point (PROBE), parallel-Arm study
    • Fogari R, Zoppi A, Mugellini A, Preti P, Destro M, Rinaldi A, Derosa G. Effectiveness of hydrochlorothiazide in combination with telmisartan and olmesartan in adults with moderate hypertension not controlled with monotherapy: A prospective, randomized, open-Label, blinded end point (PROBE), parallel-arm study. Curr Ther Res Clin Exp 2008;69:1-15.
    • (2008) Curr Ther Res Clin Exp , vol.69 , pp. 1-15
    • Fogari, R.1    Zoppi, A.2    Mugellini, A.3    Preti, P.4    Destro, M.5    Rinaldi, A.6    Derosa, G.7
  • 31
    • 0842264751 scopus 로고    scopus 로고
    • Freehand three-Dimensional echocardiographic evaluation of the effect of telmisartan compared with hydrochlorothiazide on left ventricular mass in hypertensive patients with mild-To-Moderate hypertension: A multicentre study
    • Galzerano D, Tammaro P, Cerciello A, Breglio R, Mallardo M, Lama D, Tuccillo B, Capogrosso P. Freehand three-Dimensional echocardiographic evaluation of the effect of telmisartan compared with hydrochlorothiazide on left ventricular mass in hypertensive patients with mild-To-Moderate hypertension: A multicentre study. J Hum Hypertens 2004;18:53-59.
    • (2004) J Hum Hypertens , vol.18 , pp. 53-59
    • Galzerano, D.1    Tammaro, P.2    Cerciello, A.3    Breglio, R.4    Mallardo, M.5    Lama, D.6    Tuccillo, B.7    Capogrosso, P.8
  • 32
    • 29244474389 scopus 로고    scopus 로고
    • Three-Dimensional echocardiographic and magnetic resonance assessment of the effect of telmisartan compared with carvedilol on left ventricular mass a multicenter, randomized, longitudinal study
    • Galzerano D, Tammaro P, del Viscovo L, Lama D, Galzerano A, Breglio R, Tuccillo B, Paolisso G, Capogrosso P. Three-Dimensional echocardiographic and magnetic resonance assessment of the effect of telmisartan compared with carvedilol on left ventricular mass a multicenter, randomized, longitudinal study. Am J Hypertens 2005;18: 1563-1569.
    • (2005) Am J Hypertens , vol.18 , pp. 1563-1569
    • Galzerano, D.1    Tammaro, P.2    Del Viscovo, L.3    Lama, D.4    Galzerano, A.5    Breglio, R.6    Tuccillo, B.7    Paolisso, G.8    Capogrosso, P.9
  • 33
    • 0036492008 scopus 로고    scopus 로고
    • Changes in pain perception during treatment with angiotensin converting enzyme-Inhibitors and angiotensin II type 1 receptor blockade
    • Guasti L, Zanotta D, Diolisi A, Garganico D, Simoni C, Gaudio G, Grandi AM, Venco A. Changes in pain perception during treatment with angiotensin converting enzyme-Inhibitors and angiotensin II type 1 receptor blockade. J Hypertens 2002;20: 485-491.
    • (2002) J Hypertens , vol.20 , pp. 485-491
    • Guasti, L.1    Zanotta, D.2    Diolisi, A.3    Garganico, D.4    Simoni, C.5    Gaudio, G.6    Grandi, A.M.7    Venco, A.8
  • 35
    • 34548825662 scopus 로고    scopus 로고
    • Comparison of the efficacy of morning versus evening administration of telmisartan in essential hypertension
    • Hermida RC, Ayala DE, Fernandez JR, Calvo C. Comparison of the efficacy of morning versus evening administration of telmisartan in essential hypertension. Hypertension 2007;50:715-722.
    • (2007) Hypertension , vol.50 , pp. 715-722
    • Hermida, R.C.1    Ayala, D.E.2    Fernandez, J.R.3    Calvo, C.4
  • 36
    • 60549113548 scopus 로고    scopus 로고
    • Administration-Timedependent effects of olmesartan on the ambulatory blood pressure of essential hypertension patients
    • Hermida RC, Ayala DE, Chayan L, Mojon A, Fernandez JR. Administration-timedependent effects of olmesartan on the ambulatory blood pressure of essential hypertension patients. Chronobiol Int 2009;26:61-79.
    • (2009) Chronobiol Int , vol.26 , pp. 61-79
    • Hermida, R.C.1    Ayala, D.E.2    Chayan, L.3    Mojon, A.4    Fernandez, J.R.5
  • 37
    • 55449135822 scopus 로고    scopus 로고
    • A randomized trial of the effect of an angiotensin II receptor blocker SR47436 (irbesartan) on 24-Hour blood pressure in patients with essential hypertension
    • Kawano Y, Sato Y, Yoshinaga K. A randomized trial of the effect of an angiotensin II receptor blocker SR47436 (irbesartan) on 24-Hour blood pressure in patients with essential hypertension. Hypertens Res 2008;31:1753-1763.
    • (2008) Hypertens Res , vol.31 , pp. 1753-1763
    • Kawano, Y.1    Sato, Y.2    Yoshinaga, K.3
  • 38
    • 0034032809 scopus 로고    scopus 로고
    • Comparison of atenolol, amlodipine, enalapril, hydrochlorothiazide, and losartan for antihypertensive treatment in patients with obstructive sleep apnea
    • Kraiczi H, Hedner J, PekerY, Grote L. Comparison of atenolol, amlodipine, enalapril, hydrochlorothiazide, and losartan for antihypertensive treatment in patients with obstructive sleep apnea. Am J Respir Crit Care Med 2000;161:1423-1428.
    • (2000) Am J Respir Crit Care Med , vol.161 , pp. 1423-1428
    • Kraiczi, H.1    Hedner, J.2    Pekery Grote, L.3
  • 40
    • 0033391893 scopus 로고    scopus 로고
    • A comparison of the efficacy and duration of action of candesartan cilexetil and losartan as assessed by clinic and ambulatory blood pressure after a missed dose, in truly hypertensive patients: A placebo-Controlled, forced titration study
    • Candesartan/Losartan study investigators
    • Lacourciere Y, Asmar R. A comparison of the efficacy and duration of action of candesartan cilexetil and losartan as assessed by clinic and ambulatory blood pressure after a missed dose, in truly hypertensive patients: A placebo-Controlled, forced titration study. Candesartan/Losartan study investigators. Am J Hypertens 1999;12: 1181-1187.
    • (1999) Am J Hypertens , vol.12 , pp. 1181-1187
    • Lacourciere, Y.1    Asmar, R.2
  • 41
    • 32244449465 scopus 로고    scopus 로고
    • A multicenter, 14-Week study of telmisartan and ramipril in patients with mild-To-Moderate hypertension using ambulatory blood pressure monitoring
    • Lacourciere Y, Neutel JM, Davidai G, Koval S. A multicenter, 14-Week study of telmisartan and ramipril in patients with mild-To-Moderate hypertension using ambulatory blood pressure monitoring. Am J Hypertens 2006;19:104-112.
    • (2006) Am J Hypertens , vol.19 , pp. 104-112
    • Lacourciere, Y.1    Neutel, J.M.2    Davidai, G.3    Koval, S.4
  • 42
    • 0033784560 scopus 로고    scopus 로고
    • A prospective, randomized, open-Label trial comparing telmisartan 80 mg with valsartan 80 mg in patients with mild to moderate hypertension using ambulatory blood pressure monitoring
    • Littlejohn T, MroczekW, Marbury T, VanderMaelen CP, Dubiel RF. A prospective, randomized, open-Label trial comparing telmisartan 80 mg with valsartan 80 mg in patients with mild to moderate hypertension using ambulatory blood pressure monitoring. Can J Cardiol 2000;16:1123-1132.
    • (2000) Can J Cardiol , vol.16 , pp. 1123-1132
    • Littlejohn, T.1    Mroczekw Marbury, T.2    Vandermaelen, C.P.3    Dubiel, R.F.4
  • 43
    • 32244447763 scopus 로고    scopus 로고
    • Indapamide SR versus candesartan and amlodipine in hypertension: The X-CELLENT Study
    • London G, Schmieder R, Calvo C, Asmar R. Indapamide SR versus candesartan and amlodipine in hypertension: The X-CELLENT Study. Am J Hypertens 2006;19: 113-121.
    • (2006) Am J Hypertens , vol.19 , pp. 113-121
    • London, G.1    Schmieder, R.2    Calvo, C.3    Asmar, R.4
  • 44
    • 0344289511 scopus 로고    scopus 로고
    • ABPM comparison of the antihypertensive profiles of the selective angiotensin II receptor antagonists telmisartan and losartan in patients with mild-To-Moderate hypertension
    • Mallion J, Siche J, Lacourciere Y. ABPM comparison of the antihypertensive profiles of the selective angiotensin II receptor antagonists telmisartan and losartan in patients with mild-To-Moderate hypertension. J Hum Hypertens 1999;13:657-664.
    • (1999) J Hum Hypertens , vol.13 , pp. 657-664
    • Mallion, J.1    Siche, J.2    Lacourciere, Y.3
  • 45
    • 70450200272 scopus 로고    scopus 로고
    • Effect of the angiotensin II type 1 receptor antagonist olmesartan on cerebral hemodynamics and rehabilitation outcomes in hypertensive post-Stroke patients
    • Matsumoto S, Shimodozono M, Miyata R, Kawahira K. Effect of the angiotensin II type 1 receptor antagonist olmesartan on cerebral hemodynamics and rehabilitation outcomes in hypertensive post-Stroke patients. Brain Inj 2009;23:1065-1072.
    • (2009) Brain Inj , vol.23 , pp. 1065-1072
    • Matsumoto, S.1    Shimodozono, M.2    Miyata, R.3    Kawahira, K.4
  • 46
    • 85027932825 scopus 로고    scopus 로고
    • Combining blockers of the renin-Angiotensin system or increasing the dose of an angiotensin II receptor antagonist in proteinuric patients: A randomized triple-Crossover study
    • Meier P, MaillardMP, Meier JR, Tremblay S, Gauthier T, Burnier M. Combining blockers of the renin-Angiotensin system or increasing the dose of an angiotensin II receptor antagonist in proteinuric patients: A randomized triple-Crossover study. J Hypertens 2011;29:1228-1235.
    • (2011) J Hypertens , vol.29 , pp. 1228-1235
    • Meier, P.1    Maillard, M.P.2    Meier, J.R.3    Tremblay, S.4    Gauthier, T.5    Burnier, M.6
  • 47
    • 0036015042 scopus 로고    scopus 로고
    • A comparison of candesartan, felodipine, and their combination in the treatment of elderly patients with systolic hypertension
    • Morgan T, Anderson A. A comparison of candesartan, felodipine, and their combination in the treatment of elderly patients with systolic hypertension. Am J Hypertens 2002;15:544-549.
    • (2002) Am J Hypertens , vol.15 , pp. 544-549
    • Morgan, T.1    Anderson, A.2
  • 48
    • 3543019104 scopus 로고    scopus 로고
    • Effect of candesartan and lisinopril alone and in combination on blood pressure and microalbuminuria
    • Morgan T, Anderson A, Bertram D, MacInnis RJ. Effect of candesartan and lisinopril alone and in combination on blood pressure and microalbuminuria. J Renin Angiotensin Aldosterone Syst 2004;5:64-71.
    • (2004) J Renin Angiotensin Aldosterone Syst , vol.5 , pp. 64-71
    • Morgan, T.1    Anderson, A.2    Bertram, D.3    Macinnis, R.J.4
  • 49
    • 7944233130 scopus 로고    scopus 로고
    • Effects of valsartan and nifedipine coat-Core on systemic arterial stiffness in hypertensive patients
    • Munakata M, Nagasaki A, Nunokawa T, Sakuma T, Kato H, Yoshinaga K, Toyota T. Effects of valsartan and nifedipine coat-Core on systemic arterial stiffness in hypertensive patients. Am J Hypertens 2004;17:1050-1055.
    • (2004) Am J Hypertens , vol.17 , pp. 1050-1055
    • Munakata, M.1    Nagasaki, A.2    Nunokawa, T.3    Sakuma, T.4    Kato, H.5    Yoshinaga, K.6    Toyota, T.7
  • 50
    • 0030814394 scopus 로고    scopus 로고
    • Valsartan, a new angiotensin II antagonist: Antihypertensive effects over 24 hours
    • Discussion 367-368
    • Neutel J,Weber M, Pool J, Smith D, Fitzsimmons S, Chiang YT, Gatlin M. Valsartan, a new angiotensin II antagonist: Antihypertensive effects over 24 hours. Clin Ther 1997; 19:447-458; Discussion 367-368.
    • (1997) Clin Ther , vol.19 , pp. 447-458
    • Neutel, J.1    Weber, M.2    Pool, J.3    Smith, D.4    Fitzsimmons, S.5    Chiang, Y.T.6    Gatlin, M.7
  • 51
    • 0036750076 scopus 로고    scopus 로고
    • Antihypertensive efficacy of olmesartan medoxomil, a new angiotensin II receptor antagonist, as assessed by ambulatory blood pressure measurements
    • Neutel JM, Elliott WJ, Izzo JL, Chen CL, Masonson HN. Antihypertensive efficacy of olmesartan medoxomil, a new angiotensin II receptor antagonist, as assessed by ambulatory blood pressure measurements. J Clin Hypertens (Greenwich) 2002;4: 325-331.
    • (2002) J Clin Hypertens (Greenwich) , vol.4 , pp. 325-331
    • Neutel, J.M.1    Elliott, W.J.2    Izzo, J.L.3    Chen, C.L.4    Masonson, H.N.5
  • 52
    • 0041589771 scopus 로고    scopus 로고
    • Telmisartan vs losartan plus hydrochlorothiazide in the treatment of mild-To-Moderate essential hypertension-A randomised ABPM study
    • Neutel JM, Kolloch RE, Plouin PF, Meinicke TW, Schumacher H. Telmisartan vs losartan plus hydrochlorothiazide in the treatment of mild-To-Moderate essential hypertension-a randomised ABPM study. J Hum Hypertens 2003;17:569-575.
    • (2003) J Hum Hypertens , vol.17 , pp. 569-575
    • Neutel, J.M.1    Kolloch, R.E.2    Plouin, P.F.3    Meinicke, T.W.4    Schumacher, H.5
  • 53
    • 73849138948 scopus 로고    scopus 로고
    • A randomized, double-Blind, four-Arm parallel-Group study of the efficacy and safety of azelnidipine and olmesartan medoxomil combination therapy compared with each monotherapy in Japanese patients with essential hypertension: The REZALT study
    • Ogihara T, Saruta T, Shimada K, Kuramoto K. A randomized, double-Blind, four-arm parallel-Group study of the efficacy and safety of azelnidipine and olmesartan medoxomil combination therapy compared with each monotherapy in Japanese patients with essential hypertension: The REZALT study. Hypertens Res 2009;32:1148-1154.
    • (2009) Hypertens Res , vol.32 , pp. 1148-1154
    • Ogihara, T.1    Saruta, T.2    Shimada, K.3    Kuramoto, K.4
  • 54
    • 75149195876 scopus 로고    scopus 로고
    • Maintenance of blood-Pressure-Lowering effect following a missed dose of aliskiren, irbesartan or ramipril: Results of a randomized, double-Blind study
    • Palatini P, Jung W, Shlyakhto E, Botha J, Bush C, Keefe DL. Maintenance of blood-Pressure-Lowering effect following a missed dose of aliskiren, irbesartan or ramipril: Results of a randomized, double-Blind study. J Hum Hypertens 2010;24:93-103.
    • (2010) J Hum Hypertens , vol.24 , pp. 93-103
    • Palatini, P.1    Jung, W.2    Shlyakhto, E.3    Botha, J.4    Bush, C.5    Keefe, D.L.6
  • 55
    • 77955253587 scopus 로고    scopus 로고
    • Effectiveness of barnidipine 10 or 20 mg plus losartan 50-Mg combination versus losartan 100-Mg monotherapy in patients with essential hypertension not controlled by losartan 50-Mg monotherapy: A 12-Week, multicenter, randomized, open-Label, parallel-Group study
    • Parati G, Giglio A, Lonati L, Destro M, Ricci AR, Cagnoni F, Pini C, Venco A, Maresca AM, Monza M, Grandi AM, Omboni S. Effectiveness of barnidipine 10 or 20 mg plus losartan 50-Mg combination versus losartan 100-Mg monotherapy in patients with essential hypertension not controlled by losartan 50-Mg monotherapy: A 12-Week, multicenter, randomized, open-Label, parallel-Group study. Clin Ther 2010;32:1270-1284.
    • (2010) Clin Ther , vol.32 , pp. 1270-1284
    • Parati, G.1    Giglio, A.2    Lonati, L.3    Destro, M.4    Ricci, A.R.5    Cagnoni, F.6    Pini, C.7    Venco, A.8    Maresca, A.M.9    Monza, M.10    Grandi, A.M.11    Omboni, S.12
  • 57
    • 0142093996 scopus 로고    scopus 로고
    • Central and peripheralhemodynamic effects of losartan and in combination with hydrochlorothiazide in mild to moderate essential hypertension
    • Podzolkov VI, BulatovVA, Son EA, OsI. Central and peripheralhemodynamic effects of losartan and in combination with hydrochlorothiazide in mild to moderate essential hypertension. Blood Press 2003;12:239-245.
    • (2003) Blood Press , vol.12 , pp. 239-245
    • Podzolkov, V.I.1    Bulatov, V.A.2    Son, E.A.3    Os, I.4
  • 58
    • 12344313951 scopus 로고    scopus 로고
    • A comparison of the efficacy and duration of action of telmisartan, amlodipine and ramipril in patients with confirmed ambulatory hypertension
    • Poirier L, de Champlain J, Larochelle P, Lamarre-Cliche M, Lacourciere Y. A comparison of the efficacy and duration of action of telmisartan, amlodipine and ramipril in patients with confirmed ambulatory hypertension. Blood PressMonit 2004;9:231-236.
    • (2004) Blood PressMonit , vol.9 , pp. 231-236
    • Poirier, L.1    De Champlain, J.2    Larochelle, P.3    Lamarre-Cliche, M.4    Lacourciere, Y.5
  • 59
    • 69049110017 scopus 로고    scopus 로고
    • 24-Hour and nighttime blood pressuremonitoring in type 2 diabetic hypertensive patients
    • Povedano ST, GarciaDeLa Villa G. 24-Hour and nighttime blood pressuremonitoring in type 2 diabetic hypertensive patients. J Clin Hypertens (Greenwich) 2009;11:426-431.
    • (2009) J Clin Hypertens (Greenwich) , vol.11 , pp. 426-431
    • Povedano, S.T.1    Garciadela Villa, G.2
  • 60
    • 0033913424 scopus 로고    scopus 로고
    • Comparison of three blood pressure measurement methods for the evaluation of two antihypertensive drugs: Feasibility, agreement, and reproducibility of blood pressure response
    • Ragot S, Genes N, Vaur L, Herpin D. Comparison of three blood pressure measurement methods for the evaluation of two antihypertensive drugs: Feasibility, agreement, and reproducibility of blood pressure response. Am J Hypertens 2000;13: 632-639.
    • (2000) Am J Hypertens , vol.13 , pp. 632-639
    • Ragot, S.1    Genes, N.2    Vaur, L.3    Herpin, D.4
  • 61
    • 34447253750 scopus 로고    scopus 로고
    • Effects of valsartan alone versus valsartan/simvastatin combination on ambulatory blood pressure, C-Reactive protein, lipoproteins, and monocyte chemoattractant protein-1 in patients with hyperlipidemia and hypertension
    • Rajagopalan S, Zannad F, Radauceanu A, Glazer R, Jia Y, PrescottMF, Kariisa M, Pitt B. Effects of valsartan alone versus valsartan/simvastatin combination on ambulatory blood pressure, C-Reactive protein, lipoproteins, and monocyte chemoattractant protein-1 in patients with hyperlipidemia and hypertension. Am J Cardiol 2007;100: 222-226.
    • (2007) Am J Cardiol , vol.100 , pp. 222-226
    • Rajagopalan, S.1    Zannad, F.2    Radauceanu, A.3    Glazer, R.4    Jia, Y.5    Prescott, M.F.6    Kariisa, M.7    Pitt, B.8
  • 62
    • 0036833657 scopus 로고    scopus 로고
    • Irbesartan reduces the albumin excretion rate in microalbuminuric type 2 diabetic patients independently of hypertension: A randomized double-Blind placebo-Controlled crossover study
    • Sasso FC, Carbonara O, Persico M, Iafusco D, Salvatore T, D'Ambrosio R, Torella R, Cozzolino D. Irbesartan reduces the albumin excretion rate in microalbuminuric type 2 diabetic patients independently of hypertension: A randomized double-Blind placebo-Controlled crossover study. Diabetes Care 2002;25:1909-1913.
    • (2002) Diabetes Care , vol.25 , pp. 1909-1913
    • Sasso, F.C.1    Carbonara, O.2    Persico, M.3    Iafusco, D.4    Salvatore, T.5    D'Ambrosio, R.6    Torella, R.7    Cozzolino, D.8
  • 63
    • 12744269551 scopus 로고    scopus 로고
    • Use of 24-Hour ambulatory blood pressure monitoring to assess antihypertensive efficacy: A comparison of olmesartanmedoxomil, losartan potassium, valsartan, and irbesartan
    • Smith DH,Dubiel R, Jones M. Use of 24-Hour ambulatory blood pressure monitoring to assess antihypertensive efficacy: A comparison of olmesartanmedoxomil, losartan potassium, valsartan, and irbesartan. Am J Cardiovasc Drugs 2005;5:41-50.
    • (2005) Am J Cardiovasc Drugs , vol.5 , pp. 41-50
    • Smith, D.H.1    Dubiel, R.2    Jones, M.3
  • 65
    • 0141753977 scopus 로고    scopus 로고
    • Blood pressure- and pulse pressure-Lowering effects, trough: Peak ratio and smoothness index of telmisartan compared with lisinopril
    • Stergiou GS, Efstathiou SP, Roussias LG, Mountokalakis TD. Blood pressure- and pulse pressure-Lowering effects, trough:peak ratio and smoothness index of telmisartan compared with lisinopril. J Cardiovasc Pharmacol 2003;42:491-496.
    • (2003) J Cardiovasc Pharmacol , vol.42 , pp. 491-496
    • Stergiou, G.S.1    Efstathiou, S.P.2    Roussias, L.G.3    Mountokalakis, T.D.4
  • 68
    • 44649196548 scopus 로고    scopus 로고
    • Aldosterone escape with diuretic or angiotensin-Converting enzyme inhibitor/angiotensin II receptor blocker combination therapy in patients with mild to moderate hypertension
    • Ubaid-Girioli S, Ferreira-Melo SE, Souza LA, Nogueira EA, Yugar-Toledo JC, Coca A, Moreno H Jr. Aldosterone escape with diuretic or angiotensin-Converting enzyme inhibitor/angiotensin II receptor blocker combination therapy in patients with mild to moderate hypertension. J Clin Hypertens (Greenwich) 2007;9:770-774.
    • (2007) J Clin Hypertens (Greenwich) , vol.9 , pp. 770-774
    • Ubaid-Girioli, S.1    Ferreira-Melo, S.E.2    Souza, L.A.3    Nogueira, E.A.4    Yugar-Toledo, J.C.5    Coca, A.6    Moreno, Jr.H.7
  • 70
    • 79952275464 scopus 로고    scopus 로고
    • Arandomized double-Blind, forced-Titration study to compare olmesartan medoxomil versus losartan potassium in patients with stage 1 and 2 hypertension
    • Weir MR,PunziHA, Flack JM, Stoakes KA, Chavanu KJ, LiW, Dubiel R.Arandomized, double-Blind, forced-titration study to compare olmesartan medoxomil versus losartan potassium in patients with stage 1 and 2 hypertension. Postgrad Med 2011;123:80-87.
    • (2011) Postgrad Med , vol.123 , pp. 80-87
    • Weir, M.R.1    Punzi, H.A.2    Flack, J.M.3    Stoakes, K.A.4    Chavanu, K.J.5    Li, W.6    Dubiel, R.7
  • 71
    • 0035216168 scopus 로고    scopus 로고
    • Evaluation of the 24-Hour blood pressure effects of eprosartan in patients with systemic hypertension
    • White WB,Anwar YA, Mansoor GA, Sica DA. Evaluation of the 24-Hour blood pressure effects of eprosartan in patients with systemic hypertension. Am J Hypertens 2001;14:1248-1255.
    • (2001) Am J Hypertens , vol.14 , pp. 1248-1255
    • White, W.B.1    Anwar, Y.A.2    Mansoor, G.A.3    Sica, D.A.4
  • 72
    • 1842562367 scopus 로고    scopus 로고
    • Effects of the angiotensin II receptor blockers telmisartan versus valsartan on the circadian variation of blood pressure: Impact on the early morning period
    • White WB, Lacourciere Y, Davidai G. Effects of the angiotensin II receptor blockers telmisartan versus valsartan on the circadian variation of blood pressure: Impact on the early morning period. Am J Hypertens 2004;17:347-353.
    • (2004) Am J Hypertens , vol.17 , pp. 347-353
    • White, W.B.1    Lacourciere, Y.2    Davidai, G.3
  • 73
    • 79953239152 scopus 로고    scopus 로고
    • Effects of the angiotensin receptor blocker azilsartan medoxomil versus olmesartan and valsartan on ambulatory and clinic blood pressure in patients with stages 1 and 2 hypertension
    • White WB,Weber MA, Sica D, Bakris GL, Perez A, Cao C, Kupfer S. Effects of the angiotensin receptor blocker azilsartan medoxomil versus olmesartan and valsartan on ambulatory and clinic blood pressure in patients with stages 1 and 2 hypertension. Hypertension 2011;57:413-420.
    • (2011) Hypertension , vol.57 , pp. 413-420
    • White, W.B.1    Weber, M.A.2    Sica, D.3    Bakris, G.L.4    Perez, A.5    Cao, C.6    Kupfer, S.7
  • 74
    • 29244484441 scopus 로고    scopus 로고
    • The prospective, randomized investigation of the safety and efficacy of telmisartan versus ramipril using ambulatory blood pressure monitoring (PRISMA I)
    • Williams B, Gosse P,Lowe L, Harper R. The prospective, randomized investigation of the safety and efficacy of telmisartan versus ramipril using ambulatory blood pressure monitoring (PRISMA I). J Hypertens 2006;24:193-200.
    • (2006) J Hypertens , vol.24 , pp. 193-200
    • Williams, B.1    Gosse Plowe, L.2    Harper, R.3
  • 75
    • 23044453625 scopus 로고    scopus 로고
    • Effects of losartan and amlodipine on urinary albumin excretion and ambulatory blood pressure in hypertensive type 2 diabetic patients with overt nephropathy
    • Yasuda G, Ando D, Hirawa N, Umemura S, Tochikubo O. Effects of losartan and amlodipine on urinary albumin excretion and ambulatory blood pressure in hypertensive type 2 diabetic patients with overt nephropathy. Diabetes Care 2005;28: 1862-1868.
    • (2005) Diabetes Care , vol.28 , pp. 1862-1868
    • Yasuda, G.1    Ando, D.2    Hirawa, N.3    Umemura, S.4    Tochikubo, O.5
  • 76
    • 84864717733 scopus 로고    scopus 로고
    • Trends in prevalence, awareness, management, and control of hypertension among United States adults 1999 to 2010
    • Guo F, He D, ZhangW,Walton RG. Trends in prevalence, awareness, management, and control of hypertension among United States adults, 1999 to 2010. J Am Coll Cardiol 2012;60:599-606.
    • (2012) J Am Coll Cardiol , vol.60 , pp. 599-606
    • Guo, F.1    He, D.2    Zhang, W.3    Walton, R.G.4
  • 78
    • 61649091385 scopus 로고    scopus 로고
    • Combination therapy versus monotherapy in reducing blood pressure: Meta-Analysis on 11,000 participants from 42 trials
    • Wald DS, Law M, Morris JK, Bestwick JP, Wald NJ. Combination therapy versus monotherapy in reducing blood pressure: Meta-analysis on 11,000 participants from 42 trials. Am J Med 2009;122:290-300.
    • (2009) Am J Med , vol.122 , pp. 290-300
    • Wald, D.S.1    Law, M.2    Morris, J.K.3    Bestwick, J.P.4    Wald, N.J.5
  • 79
    • 84862119222 scopus 로고    scopus 로고
    • European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The fifth joint task force of the European society of cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts)
    • Perk J,DeBacker G, Gohlke H, GrahamI, Reiner Z, VerschurenM, Albus C, Benlian P, Boysen G, Cifkova R, Deaton C, Ebrahim S, Fisher M, Germano G, Hobbs R, Hoes A, Karadeniz S, Mezzani A, Prescott E, Ryden L, Scherer M, Syvanne M, Scholte op Reimer WJ, Vrints C,Wood D, Zamorano JL, Zannad F. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur Heart J 2012;33:1635-1701.
    • (2012) Eur Heart J , vol.33 , pp. 1635-1701
    • Perk, J.1    Debacker, G.2    Gohlke, H.3    Grahami Reiner, Z.4    Verschurenm Albus, C.5    Benlian, P.6    Boysen, G.7    Cifkova, R.8    Deaton, C.9    Ebrahim, S.10    Fisher, M.11    Germano, G.12    Hobbs, R.13    Hoes, A.14    Karadeniz, S.15    Mezzani, A.16    Prescott, E.17    Ryden, L.18    Scherer, M.19    Syvanne, M.20    more..
  • 80
    • 0037490085 scopus 로고    scopus 로고
    • Value of low dose combination treatment with blood pressure lowering drugs: Analysis of 354 randomised trials
    • Law MR,Wald NJ, Morris JK, Jordan RE. Value of low dose combination treatment with blood pressure lowering drugs: Analysis of 354 randomised trials. BMJ 2003; 326:1427.
    • (2003) BMJ , vol.326 , pp. 1427
    • Law, M.R.1    Wald, N.J.2    Morris, J.K.3    Jordan, R.E.4
  • 81
    • 34250179723 scopus 로고    scopus 로고
    • Fixed-Dose combinationsimprovemedicationcompliance: Ameta-Analysis
    • Bangalore S, Kamalakkannan G, Parkar S, Messerli FH. Fixed-Dose combinationsimprovemedicationcompliance: Ameta-analysis.AmJMed 2007;120:713-719.
    • (2007) Am J Med , vol.120 , pp. 713-719
    • Bangalore, S.1    Kamalakkannan, G.2    Parkar, S.3    Messerli, F.H.4
  • 82
    • 0032840006 scopus 로고    scopus 로고
    • Losartan was no better than placebo
    • Messerli FH. . . . and losartan was no better than placebo. J Hum Hypertens 1999;13: 649-650.
    • (1999) J Hum Hypertens , vol.13 , pp. 649-650
    • Messerli, F.H.1
  • 83
    • 0032746436 scopus 로고    scopus 로고
    • Time course and extent of angiotensin II antagonism after irbesartan, losartan, and valsartan in humans assessed by angiotensin II dose response and radioligand receptor assay
    • Belz GG, Butzer R, Kober S, Mang C, Mutschler E. Time course and extent of angiotensin II antagonism after irbesartan, losartan, and valsartan in humans assessed by angiotensin II dose response and radioligand receptor assay. Clin Pharmacol Ther 1999;66:367-373.
    • (1999) Clin Pharmacol Ther , vol.66 , pp. 367-373
    • Belz, G.G.1    Butzer, R.2    Kober, S.3    Mang, C.4    Mutschler, E.5
  • 84
    • 0033025045 scopus 로고    scopus 로고
    • Angiotensin II receptor blockade in normotensive subjects: A direct comparison of three AT1 receptor antagonists
    • Mazzolai L, Maillard M, Rossat J, Nussberger J, Brunner HR, Burnier M. Angiotensin II receptor blockade in normotensive subjects: A direct comparison of three AT1 receptor antagonists. Hypertension 1999;33:850-855
    • (1999) Hypertension , vol.33 , pp. 850-855
    • Mazzolai, L.1    Maillard, M.2    Rossat, J.3    Nussberger, J.4    Brunner, H.R.5    Burnier, M.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.